Skip to main content
. 2020 Apr 8;87(3):538–546. doi: 10.1093/neuros/nyaa054

TABLE 4.

Summary of Studies Reporting IGF-1 Index As a Predictor of Treatment Failure

Study N Median IGF-1 index (range) IGF-1i threshold assessed HR (95% CI), P value
Pollock et al, 200737 46 2.25 (1.05-7.0) 2.25 2.9 (1.2-6.9), .02
Losa et al, 200841 83 1.83 (1.35-2.56)b 1.83 2.6 (1.3-5.1), .01
Liu et al, 201242 40 1.9 (0.8-4.6) 1.5 9.7 (2.3-40), .002
Kong et al, 201940 138 NR 2.0 2.3 (1.2-4.5), .01
Present study (IGF-1i ≥ 2.25)a 102 1.66 (1.37-3.22)b 2.25 2.0 (1.1-3.8), .02

HR, hazard ratio; IGF-1i, insulin-like growth factor-1 index; IQR, interquartile range; NR, not reported.

aCohort partially overlaps with Pollock et al37; data reported Table 4 transformed to HR for treatment failure, to facilitate interpretation.

bIQR reported.